AKUMS DRUGS & PHARMACEUTICALS
Back to Balance Sheet
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,905 Cr | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr |
What is the latest Total Liabilities ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,905 Cr |
| Mar2024 | ₹3,393 Cr |
| Mar2023 | ₹3,235 Cr |
| Mar2022 | ₹3,050 Cr |
| Mar2021 | ₹2,152 Cr |
How is Total Liabilities of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,905 Cr | 15.09 | |
| Mar2024 | ₹3,393 Cr | 4.89 | |
| Mar2023 | ₹3,235 Cr | 6.06 | |
| Mar2022 | ₹3,050 Cr | 41.73 | |
| Mar2021 | ₹2,152 Cr | - | |
Compare Total Liabilities of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹8,431.1 Cr | 3.6% | 3.6% | -8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 3.6% |
3.6% |
-8.7% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses